Your browser doesn't support javascript.
loading
Fulminant type 1 diabetes: A comprehensive review of an autoimmune condition.
Luo, Shuoming; Ma, Xiaoxi; Li, Xia; Xie, Zhiguo; Zhou, Zhiguang.
Afiliação
  • Luo S; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Ma X; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education; National Clinical Research Center for Metabolic Diseases, Changsha, China.
  • Li X; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Xie Z; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education; National Clinical Research Center for Metabolic Diseases, Changsha, China.
  • Zhou Z; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.
Diabetes Metab Res Rev ; 36(6): e3317, 2020 09.
Article em En | MEDLINE | ID: mdl-32223049
ABSTRACT
Fulminant type 1 diabetes (FT1D) is a subset of type 1 diabetes characterized by extremely rapid pancreatic ß-cell destruction with aggressive progression of hyperglycaemia and ketoacidosis. It was initially classified as idiopathic type 1 diabetes due to the absence of autoimmune markers. However, subsequent studies provide evidences supporting the involvement of autoimmunity in rapid ß-cell loss in FT1D pathogenesis, which are crucial for FT1D being an autoimmune disease. This article highlights the role of immunological aspects in FT1D according to the autoimmune-associated genetic background, viral infection, innate immunity, adaptive immunity, and pancreas histology.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoimunidade / Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Células Secretoras de Insulina / Hiperglicemia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Autoimunidade / Cetoacidose Diabética / Diabetes Mellitus Tipo 1 / Células Secretoras de Insulina / Hiperglicemia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article